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Background: ATP-gated P2X3 receptors of sensory ganglion neurons are important transducers of pain as they
adapt their expression and function in response to acute and chronic nociceptive signals. The present study
investigated the role of calcium/calmodulin-dependent serine protein kinase (CASK) in controlling P2X3 receptor
expression and function in trigeminal ganglia from Cacna1a R192Q-mutated knock-in (KI) mice, a genetic model for
familial hemiplegic migraine type-1.
Results: KI ganglion neurons showed more abundant CASK/P2X3 receptor complex at membrane level, a result
that likely originated from gain-of-function effects of R192Q-mutated CaV2.1 channels and downstream enhanced
CaMKII activity. The selective CaV2.1 channel blocker ω-Agatoxin IVA and the CaMKII inhibitor KN-93 were sufficient
to return CASK/P2X3 co-expression to WT levels. After CASK silencing, P2X3 receptor expression was decreased in
both WT and KI ganglia, supporting the role of CASK in P2X3 receptor stabilization. This process was functionally
observed as reduced P2X3 receptor currents.
Conclusions: We propose that, in trigeminal sensory neurons, the CASK/P2X3 complex has a dynamic nature
depending on intracellular calcium and related signaling, that are enhanced in a transgenic mouse model of
genetic hemiplegic migraine.
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P2X3 receptors are predominantly expressed on sensory
ganglion neurons where they play an important role in
transducing pain signals [1]. A major property of these
receptors is the ability to rapidly adapt their function to
extracellular milieu changes by trafficking-mediated re-
ceptor redistribution, by modulation of receptor function
through intracellular kinases, or by interaction with spe-
cific scaffold proteins [2-5]. We recently reported that
under basal conditions P2X3 receptors are strongly asso-
ciated with the multifunction scaffold protein calcium/
calmodulin-dependent serine protein kinase (CASK) [6].* Correspondence: Elsa.Fabbretti@ung.si
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distribution, and reproduction in any mediumIn the present study we investigated whether the CASK/
P2X3 complex was altered and functionally linked to
sensitization of P2X3 receptors in transgenic knock-in
(KI) mice exhibiting a gain-of-function phenotype of
voltage-gated CaV2.1 (P/Q-type) calcium channels, due
to a R192Q missense mutation in the channel α1 sub-
unit that causes familial hemiplegic migraine type 1
(FHM-1) [7,8]. Using this KI mouse model, we previously
identified multiple CaV2.1 channel interactors (calcineurin,
Cdk5 and CaMKII) that modulate P2X3 receptor function
in trigeminal sensory neurons [9-12]. In particular, en-
hanced P2X3 receptor-mediated responses were found in
KI neurons that depend on constitutive activation of CaM-
KII and are reversed by the selective CaV2.1 channel
blocker or by the CaMKII inhibitor [9]. Previous studies
showed that CASK is associated with calcium channels
[13-15] and, thus, provide the rational to explore if theentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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sembly and function. The present study aimed at testing,
with molecular biology and electrophysiological methods,
the properties of the CASK/P2X3 receptor complex in this
mouse model expressing gain-of-function of CaV2.1 chan-
nels, using primary cultures of trigeminal ganglia that fully
retain the basal characteristics of the CASK/P2X3 com-
plex in vivo [6].W
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Figure 1 CASK/P2X3 complex in KI trigeminal neurons. A, Example of
antibodies reveals more abundant CASK/P2X3 complex in KI ganglion cultu
Ab, indicate signal from unrelated antibody. B, CASK/P2X3 co-immunoprec
P2X3 complex is sensitive to ω-Agatoxin IVA treatment (400 nM, overnight
in A. P2X3 immunoprecipitation input and β-Tubulin expression shown as
pre-incubation (5 μM, 90 min). D, Examples of anti-phospho-CaMKII T286 W
control conditions and after CASK silencing. β-Tubulin is shown as loading
and p = 0.025 for KI; n = 3).Results
The CASK/P2X3 receptor complex is abundantly
expressed in KI ganglia and is modulated by Ca2+ influx
In order to study the effects of CASK on P2X3 receptors
expressed in WT and KI ganglia, we first compared
CASK/P2X3 complex levels in ganglion extracts. Immu-
noprecipitation experiments showed that the complex was
significantly more abundant in KI than in WT samplesKN-93:
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http://www.molecularpain.com/content/9/1/62(Figure 1A; p = 0.038, n = 5). A significant increase (n = 5,
p = 0.005) in CASK associated with cell membrane
fractions was observed in KI tissue (Additional file 1:
Figure S1A), although total CASK lysate preparations
did not show any difference between WT or KI samples
(Additional file 1: Figure S1B). Further experiments con-
cerning the specificity of the CASK/P2X3 complex, based
on immunoprecipitating CASK first and then performing
western blotting with P2X3 antibodies, validated our pre-
vious findings [6] and are included in Additional file 2:
Figure S2A, B.
In analogy to its effect on other receptors (e.g. NMDA
receptors; [15]), CASK might exert a role in the process
of P2X3 receptor export to surface membranes. In fact,
pulled-down biotinylated surface P2X3 receptors showed
co-purification with intracellular CASK (Additional file 3:
Figure S3), supporting the view that CASK/P2X3 com-
plexes are membrane-bound. In these biotinylation experi-
ments, no difference was observed in the levels of surface
membrane CASK in WTand KI samples (Additional file 3:
Figure S3).
We further explored whether the origin of the stron-
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Figure 2 Effect of siCASK silencing in KI and WT neurons. A, Example
and after siCASK silencing. Note the significant decrease in P2X3 receptor e
reduction of P2X3 protein expression in silenced samples (*p = 0.026 for W
examples of currents induced by α,β-meATP (α,β, black bar, 10 μM) from W
quantification of mean current amplitude values (WT: 230 ± 19 pA or 170 ±
# p = 0.036, *p = 0.02 for WT and p = 0.019 for KI; n = 15–23 cells.directly linked to the CaV2.1 R192Q gain-of-function
and concomitant higher CaMKII activation [9]. To this
end, we used selective pharmacological tools to specific-
ally block either CaV2.1 channel function or apply inhib-
itors of downstream CaMKII activity. Trigeminal
ganglion cultures were treated with the selective CaV2.1
channel blocker ω-Agatoxin IVA (400 nM, 15 h) and
then tested for CASK/P2X3 protein interaction by im-
munoprecipitation. Immunoprecipitation experiments
with purified P2X3 receptors and CASK expression
(Figure 1B) confirmed that CASK/P2X3 receptor inter-
action was stronger in KI cultures and that it was sig-
nificantly reversed by ω-Agatoxin IVA application.
Interestingly, CASK/P2X3 complex in WT culture was
not affected by the channel blocker suggesting that lar-
ger CASK/P2X3 interaction in KI neurons was likely
due to the enhanced CaV2.1 channel activity.
Likewise, after cultures treatment with the CaMKII
inhibitor KN-93 (5 μM, 90 min, Figure 1C), the CASK/
P2X3 interaction was significantly inhibited in KI, but
not in WT (Figure 1C). In addition, after RNA silen-
cing of CASK expression [6], there was a significant
decrease in CaMKII phosphorylation (Figure 1D).0
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ganglion cultures
Our recent findings [6] that showed how siCASK signifi-
cantly lowered P2X3 expression in trigeminal ganglion cul-
tures, have been further validated in the present study in
which no difference between WT and KI cultures was ob-
served as a consequence of siCASK (Figure 2A). To further
explore functional consequence of CASK/P2X3 complex
in the KI model, patch clamp experiments were carried out
(Figure 2B). Sample P2X3 receptor currents elicited by
pulse application of the selective agonist α,β-methylene-ad-
enosine-5′-triphosphate (α,β-meATP; 10 μM) were clearly
smaller after siCASK silencing, but proportionally similar
in WT and KI neurons. As expected [9], KI neuronal cur-
rents were constitutively larger than WT ones (Figure 2B).
Discussion
The principal finding of the present study is the demon-
stration that the R192Q missense mutation in the α1 sub-
unit of CaV2.1 calcium channels, that confers gain of
function to these channels, is associated with more abun-
dant CASK/P2X3 complex in trigeminal sensory neurons
with a mechanism clearly dependent on CaV2.1 channel
function and CaMKII activation. This result outlines a mo-
lecular mechanism whereby P2X3 receptors are retained
and display stronger activity in KI neurons and can, there-
fore, contribute to sensitization to painful stimuli.
Our former studies have shown that P2X3 receptors of
trigeminal sensory neurons are under the influence of
endogenous kinases such as Csk and Cdk5, whichA
B
Figure 3 Proposed mechanism of action of CASK/P2X3 complex in tri
and CaV2.1 channel protein interactions at the plasma membrane of trigem
receptors is thought to be associated with CASK that ensures their stable e
minor contribution to Ca2+ influx, and the dynamic CASK/P2X3 association
KI ganglia, the hyperfunctional CaV2.1 channels result in a stronger Ca
2+ inf
complexes with improved stability of P2X3 receptors. Sub-membrane vesicle-
also indicated. Larger release of extracellular ATP [20] facilitates P2X3 responseregulate the basal operational activity of these receptors
[9,16]. We have recently observed a new member of this
class of regulators, namely CASK, which strongly
controls P2X3 receptor expression and function at the
plasma membrane of mouse trigeminal neurons under
physiological conditions [6,17]. The present report
shows that CASK is more associated with P2X3 recep-
tors in KI ganglia and in culture, and that this associ-
ation is largely dependent on CaV2.1 calcium channel
and CAMKII activity as their specific pharmacological
blockers reversed the effect. When CASK expression
was inhibited by siRNA silencing, the P2X3 receptor
expression and function fell to similar levels in WT and
KI neurons. In biotinylation experiments, since no dif-
ference was observed in CASK fractions from WT or
KI surface membrane samples, these experiments are,
therefore, consistent with a differential distribution of
P2X3 receptors to lipid raft compartments in KI ganglia
[3]. When CASK was blocked, the residual P2X3 recep-
tor currents were approximately one-third smaller, pro-
viding a first estimate about the extent of the role of
CASK in regulating P2X3 receptor activity. Such data
suggest that the stronger CASK/P2X3 association in KI
cells was an important factor for the observed up-
regulation of P2X3 receptors.
Figure 3 summarizes an idealized scheme of how we
envisage the interaction between certain neuronal pro-
teins affecting P2X3 receptor responsiveness. In WT
neurons, only a fraction of P2X3 receptors is thought to
be associated with CASK, which ensures their stability atgeminal sensory neurons. Schematic representation of CASK, P2X3,
inal sensory neurons. A, In WT ganglion cells, only a fraction of P2X3
xpression. Under these conditions, CaV2.1 channels provide only a
ensures physiological responses and P2X3 receptors turn-over [6]. B, In
lux, larger CaMKII activity, and more abundant CASK/P2X3 receptor
associated CASK, potentially associated with P2X3 receptor trafficking, is
s and may contribute to the process of sensitization of P2X3 receptors.
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CaV2.1 channel activity provides only a relatively minor
contribution to Ca2+ influx [9,18,19] and P2X3 receptors
are regulated only to limited extent by CASK (Csk and
Cdk5 are not depicted here). The hyper-functional
CaV2.1 channels in KI (that require a smaller membrane
depolarization to reach the activation threshold [8,20])
induce stronger Ca2+ influx and CaMKII activity [9], im-
proving the stability of CASK/P2X3 receptor complexes
and their activity at plasma membrane level. Further-
more, these processes probably synergize and add to the
already larger release of extracellular ATP by KI ganglia
[21], thereby further facilitating P2X3 responses and
thus contributing to the process of sensitization of P2X3
receptors [9].
In conclusion, the present data suggest that CASK
could play the role of scaffold protein linking different
membrane and sub-membrane molecules (including
other channels) to elicit further downstream signaling.
Since CASK is involved at presynaptic level to modulate
synaptic transmitter release [22], it is feasible that this
anchoring mechanism may also occur at central level
and shows distinct alterations in chronic pain.
Materials and methods
Tissue culture
CaV2.1 R192Q KI and WT mice [8] were euthanized
by slowly raising levels of CO2 in accordance with the
Italian Animal Welfare Act and approved by SISSA
Ethical Committee. Trigeminal ganglia primary cultures
were obtained as previously described [6]. In specific ex-
periments ω-Agatoxin IVA (400 nM; 15 h; Sigma, Milan,
Italy) or CaMKII inhibitor KN-93 (5 μM; Sigma) were
added to the culture medium for the indicated time [9].
CASK siRNA experiments were performed as previously
reported [6].
Western blotting and immunoprecipitation
Protein extracts and immunoprecipitation experiments
and membrane protein biotinylation were performed as
previously described [6]. P2X3 receptors were solubilized
in 10 mM Tris–HCl (pH 7.5), 150 mM NaCl, 20 mM
EDTA, and 1% Triton-X-100 plus protease inhibitors
(Roche Products, Welwyn Garden City, UK) as previ-
ously reported [3,6]. The non-ionic detergent n-octyl-β-
D-glucoside (ODG; [9]) was not used. For western blot
quantification, signals expressed in optical density abso-
lute units (AU) were measured with digital imaging sys-
tem (UVITEC, Cambridge, UK).
Patch clamp recordings
Currents from siRNA-treated cultures (72 h) were re-
corded under whole cell voltage clamp mode at holding
potential of −65 mV after correcting for the liquidjunction potential [6]. P2X3 receptor synthetic agonist
α,β-meATP (10 μM; Sigma) was applied (2 s) using a fast
superfusion system (RSC-200; BioLogic Science Instru-
ments, Claix, France).
Data analysis
Data are presented as mean ± standard error. Statistical
significance was evaluated with paired Student’s t-test
or Mann–Whitney rank sum test using OriginPro 7.5
(OriginLab, Northampton, MA, USA).
Additional files
Additional file 1: Figure S1. A, B Example of a Western blot
experiment of total trigeminal ganglia extracts (A) or total membrane or
ganglia samples (B) from WT and KI mice tested with anti-CASK antibodies.
Histogram quantifications show no difference of total CASK expression in
WT and KI (n = 3; p > 0.05), and a significant enrichment of total membrane-
associated CASK expression in KI vs WT (n = 5, p = 0.005). Actin was used as
gel loading control.
Additional file 2: Figure S2. A, Western blot experiment of trigeminal
ganglia extracts after immunoprecipitation with anti-CASK and revealed
with anti-CASK or anti-P2X3 antibodies. β-Actin signals quantify
immunoprecipitation input. B, Membrane protein biotinylation experiments
of trigeminal ganglia cultures in control and after siP2X3, analysed with
western blot and probed with anti-CASK or anti-P2X3 antibodies, as
indicated. Signals from total extracts (left) and streptavidin pull-down
(right) of biotinylated samples are shown. No difference in membrane-
bound CASK after siP2X3 is found β-Actin is used as gel loading control.
Note lack of β-Actin in pull-down samples.
Additional file 3: Figure S3. Membrane protein biotinylation
experiments of WT and KI trigeminal ganglia cultures in control and after
siP2X3, revealed with western blot and probed with anti-CASK and anti-P2X3
antibodies. Signals from total extracts (left) and streptavidin pull-down (right)
of biotinylated samples are shown. β-Actin is used as gel loading control.
Histograms quantify larger surface P2X3 receptors in trigeminal ganglia
cultures from KI mice and no changes in surface-associated CASK between
WT and KI samples (n = 3, *p < 0.05).
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